Gates Foundation Collaborates with the Consortium of Life Sciences Companies to Address Challenges Against the Pandemic COVID-19
Shots:
- Novartis along with multiple pharmaceutical companies work in collaboration with the Gates Foundation to accelerate the development- manufacturing and delivery of vaccines- diagnostics and other treatments to combat COVID-19
- The collaboration will bring a range of assets- resources- and expertise required to identify effective & scalable solutions targeting the pandemic
- Fifteen pharmaceutical companies will share their molecular compound libraries with the COVID-19 Therapeutics Accelerator launched by the Gates Foundation- Wellcome- and Mastercard for screening the potential of therapies against COVID-19
Click here to read full press release/ article | Ref: Novartis | Image: BORGEN Magazine
This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com